Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Motlatji Reratilwe Bonnie Maloba"'
Autor:
Yolandi Snyman, Sandra Reuter, Andrew Christopher Whitelaw, Lisa Stein, Motlatji Reratilwe Bonnie Maloba, Mae Newton-Foot
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 102-106 (2021)
ABSTRACT: Objectives: Colistin resistance in Acinetobacter spp. is increasing, resulting in potentially untreatable nosocomial infections. Plasmid-mediated colistin resistance is of particular concern due to its low fitness cost and potential transfe
Externí odkaz:
https://doaj.org/article/6b49847ef9f3429dab82b07ab8629f8d
Autor:
Yolandi Snyman, Andrew Christopher Whitelaw, Sandra Reuter, Angela Dramowski, Motlatji Reratilwe Bonnie Maloba, Mae Newton-Foot
Publikováno v:
International Journal of Infectious Diseases, Vol 91, Iss , Pp 94-100 (2020)
Objectives: To describe colistin-resistant Acinetobacter baumannii isolates in Cape Town, South Africa. Methods: A. baumannii isolates identified on Vitek 2 Advanced Expert System were collected from Tygerberg Hospital referral laboratory between 201
Externí odkaz:
https://doaj.org/article/cac988bd2cc84d9f92caa62541095676
Autor:
Mae Newton-Foot, Yolandi Snyman, Motlatji Reratilwe Bonnie Maloba, Andrew Christopher Whitelaw
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 6, Iss 1, Pp 1-7 (2017)
Abstract Background Colistin is a last resort antibiotic for the treatment of carbapenem-resistant Gram negative infections. Until recently, mechanisms of colistin resistance were limited to chromosomal mutations which confer a high fitness cost and
Externí odkaz:
https://doaj.org/article/b21ba7438e834099963232d9703eec7b
Autor:
Mae Newton-Foot, Yolandi Snyman, Sandra Reuter, Andrew Whitelaw, Motlatji Reratilwe Bonnie Maloba
Publikováno v:
Microbial Drug Resistance. 27:1249-1258
Objectives: Colistin is a last-resort antibiotic for the treatment of carbapenem-resistant Gram-negative infections. Colistin resistance thus poses a threat to human health. Colistin resistance is ...
Autor:
Jo M. Barnes, Mae Newton-Foot, Andrew Whitelaw, Motlatji Reratilwe Bonnie Maloba, Yolandi Snyman
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-9 (2021)
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control
Background Colistin is regarded as a last-resort antimicrobial against multi-drug resistant Gram-negative bacteria (GNB), therefore the dissemination of colistin resistance in the environment is of great concern. Horizontal transfer of mobile colisti
Autor:
Motlatji Reratilwe Bonnie Maloba, Andrew Whitelaw, Mae Newton-Foot, Yolandi Snyman, Angela Dramowski, Sandra Reuter
Publikováno v:
International Journal of Infectious Diseases, Vol 91, Iss, Pp 94-100 (2020)
Objectives: To describe colistin-resistant Acinetobacter baumannii isolates in Cape Town, South Africa. Methods: A. baumannii isolates identified on Vitek 2 Advanced Expert System were collected from Tygerberg Hospital referral laboratory between 201
Autor:
Colette Pienaar, Kessendri Reddy, Motlatji Reratilwe Bonnie Maloba, Sebastian Gericke, Helena Rabie
Publikováno v:
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e5 (2021)
Southern African Journal of Infectious Diseases
Southern African Journal of Infectious Diseases
Corynebacterium pseudodiphtheriticum is an established member of the normal flora of the respiratory tract. This organism is an emerging cause of respiratory tract infection, as well as infection of the skin and skin structures, urinary tract and oth
Autor:
Yolandi, Snyman, Andrew Christopher, Whitelaw, Sandra, Reuter, Motlatji Reratilwe Bonnie, Maloba, Mae, Newton-Foot
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.). 27(9)
Autor:
Motlatji Reratilwe Bonnie Maloba, Mae Newton-Foot, Lisa Stein, Sandra Reuter, Andrew Whitelaw, Yolandi Snyman
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss, Pp 102-106 (2021)
Objectives Colistin resistance in Acinetobacter spp. is increasing, resulting in potentially untreatable nosocomial infections. Plasmid-mediated colistin resistance is of particular concern due to its low fitness cost and potential transferability to
Autor:
Anneke C. Hesseling, Mae Newton-Foot, Motlatji Reratilwe Bonnie Maloba, Andrew Whitelaw, Yolandi Snyman
Publikováno v:
Southern African Journal of Infectious Diseases
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e4 (2021)
Southern African Journal of Infectious Diseases, Vol 36, Iss 1, Pp e1-e4 (2021)
Colistin is a last-resort antibiotic against multidrug-resistant, Gram-negative bacteria. Colistin resistance has been described in the clinical settings in South Africa. However, information on carriage of these bacteria in communities is limited. T